Skip to content

Effect of the Sustainable Diet on Gut Microbiota and the Metabolome: a Randomised Crossover Study

Effect of the Sustainable Diet on Gut Microbiota and the Metabolome: a Randomised Crossover Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05231317
Acronym
SUSUGUT
Enrollment
20
Registered
2022-02-09
Start date
2021-07-02
Completion date
2021-12-17
Last updated
2022-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Microbiota, Nutrition, Healthy

Keywords

Plant-based diet, Western diet, Gut microbiota,, Trimethylamine N-oxide, Human intervention study.

Brief summary

Unhealthy diets are closely linked to non-communicable diseases and constitute higher risk of morbidity and mortality than unsafe sex, alcohol, tobacco and drugs use combined. According to the World Health Organization (WHO), a healthy diet follows a plant-based pattern with low quantities of red meat and a low simple sugar intake. It would also reduce anthropological ecologic impact. We hypothesize that a plant-based diet will beneficially modify the gut microbiota and metabolome, influencing also Trimethylamine N-oxide (TMAO), a metabolite associated to CVD. This study has a randomized single blind crossover design that compares a plant-based diet towards a control western diet. It is applied to volunteers aged 18-70 years, N=20. Each dietary intervention (plant-based and western) would last for 16 consecutive days separated by a minimum of 7 weeks washout period (intervention 1-washout-intervention 2). Samples of blood urine and faeces will be collected at day 1 and 14 of each intervention. On day 14 will be performed L-carnitine challenge with 1200mg of L-carnitine to test the levels of TMAO), in for the next 2 consecutive days (24h and 48h post treatment).

Interventions

OTHERPlant-based diet

16 days with all foods provided

16 days with all foods provided

Sponsors

Fondazione Edmund Mach
CollaboratorOTHER
University of Ulster
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Masking description

Single-blind

Intervention model description

Cross-over single-blinded

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Free-living, apparently healthy adults * Bmi\>18 * Aged 18-70 years at recruitment * Non-smokers

Exclusion criteria

* Non-free-living adults * Adults \<18 or \>70 years at recruitment * BMI\<18 * Current smokers

Design outcomes

Primary

MeasureTime frameDescription
Gut microbiota changesChange over 14 daysSignificant changes in the number of bifidobacteria
Quantification of Trimethylamine N-oxideDay 16Changes in response to L-Carnitine challenge

Secondary

MeasureTime frameDescription
Ex vivo effects of faecal water on gut pathobiontsDay 14Co-culturing the aqueous phase of faeces with C. difficile to assess changes in its biology
Bioactivity of faecal waterChange over 14 daysMeasured by using faecal water as basis for growth media (ex vivo measure)
Quantification of Short Chain Fatty Acids (SCFA)Change over 14 daysMeasured by nuclear magnetic resonance (NMR)
Quantification of phytochemicalsChange over 14 daysMeasured by LC-MS
Effects on inflammatory markers of both dietsChange over 14 daysCytokine analysis via ELISA test (MagPix)

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026